RPM Global (ASX: RUL) FY 2024 Result Shows Improved Disclosure
Net profit before tax was up 71% to $10.2 million.
Net profit before tax was up 71% to $10.2 million.
SiteMinder (ASX: SDR) made a loss in FY 2024 but there are signs the business is improving in quality.
Scientists have little to gain from investigating popular beliefs like astrology, but we all benefit when they do.
Profit before tax was down 10%, but if you accept the company’s various “one off” adjustments, it was up 10%.
A couple of delayed contracts muted growth, but free cashflow was extraordinarily strong.
All that Glitters recounts the heady ascent and sharp fall that Orlando Whitfield and Inigo Philbrick experienced as they shot through into the much-too-rich beating heart of the art market, not to be mistaken with the art world.
Evaluating the Kip McGrath Education Centre (ASX: KME) FY 2024 Results.
Qualitative political research findings as Dutton takes 2PP poll lead.
Vysarn (ASX: VYS) grew profit before tax at over 50% in FY 2024 (and profit after tax growth was even better).
Massive ‘cruisezillas’ face backlash over greenhouse gas emissions, but industry leaders say eco alternatives aren’t practical.
Energy One (ASX: EOL) produced record revenue in FY 2024, though profit was down.
REA Group (ASX: REA) is going really well in Australia where it dominates already, but success is far from certain in India, where it hopes to grow.
Directors have been buying shares in Silk Logistics Holdings (ASX: SLH) at around current levels.
Audinate (ASX: AD8) continues to smash the competition, and the Audinate share price is recovering from being smashed by negative outlook.
A strong performance in FY 2024 saw earnings and dividends per share come in slightly above what I’d been hoping for.
The long term thesis remains in place but significant reinvestment in the business will depress profits in the short term.
Each book will suit an art audience with in-jokes, satire and some critique, but happily both tackle finance, politics and power.
High concentrations of toxic minerals at sites identified by indigenous elders.
The Pro Medicus (ASX: PME) share price gained more than 8% after it reported another set of strong results, beating analyst estimates.